88 related articles for article (PubMed ID: 9690380)
1. Novel expression and regulation of gastrin gene in human ovarian cancer cell line, SW626.
Kim HJ; Evers BM; Banker NA; Greeley GH; Hellmich MR; Thompson JC; Townsend CM
Dig Dis Sci; 1998 Jul; 43(7):1465-73. PubMed ID: 9690380
[TBL] [Abstract][Full Text] [Related]
2. Bombesin-mediated AP-1 activation in a human gastric cancer (SIIA).
Kim HJ; Evers BM; Guo Y; Banker NA; Hellmich MR; Townsend CM
Surgery; 1996 Aug; 120(2):130-6; discussion 136-7. PubMed ID: 8751574
[TBL] [Abstract][Full Text] [Related]
3. Effective inhibition of experimental human ovarian cancers with a targeted cytotoxic bombesin analogue AN-215.
Engel JB; Keller G; Schally AV; Halmos G; Hammann B; Nagy A
Clin Cancer Res; 2005 Mar; 11(6):2408-15. PubMed ID: 15788692
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of proliferation and migration of a colorectal cancer cell line by amidated and glycine-extended gastrin-releasing peptide via the same receptor.
Patel O; Dumesny C; Giraud AS; Baldwin GS; Shulkes A
Biochem Pharmacol; 2004 Dec; 68(11):2129-42. PubMed ID: 15498503
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms.
Fleischmann A; Waser B; Reubi JC
Cell Oncol; 2007; 29(5):421-33. PubMed ID: 17726264
[TBL] [Abstract][Full Text] [Related]
6. Nonconstitutive expression of the gastrin-releasing peptide autocrine growth system in human small cell lung carcinoma NCI-H345 cells.
Aguayo SM; Miller Y; Boose D; Holley M; Portanova LB; Schuyler KD; Kane MA
Cell Growth Differ; 1996 May; 7(5):563-72. PubMed ID: 8732666
[TBL] [Abstract][Full Text] [Related]
7. Expression of mRNA for gastrin-releasing peptide receptor by human bronchial epithelial cells. Association with prolonged tobacco exposure and responsiveness to bombesin-like peptides.
Siegfried JM; DeMichele MA; Hunt JD; Davis AG; Vohra KP; Pilewski JM
Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):358-66. PubMed ID: 9279210
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer.
Dalm SU; Martens JW; Sieuwerts AM; van Deurzen CH; Koelewijn SJ; de Blois E; Maina T; Nock BA; Brunel L; Fehrentz JA; Martinez J; de Jong M; Melis M
J Nucl Med; 2015 May; 56(5):752-7. PubMed ID: 25791989
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists.
Chatzistamou I; Schally AV; Sun B; Armatis P; Szepeshazi K
Br J Cancer; 2000 Oct; 83(7):906-13. PubMed ID: 10970693
[TBL] [Abstract][Full Text] [Related]
10. Human glioblastoma cell lines have neuropeptide receptors for bombesin/gastrin-releasing peptide.
Moody TW; Mahmoud S; Staley J; Naldini L; Cirillo D; South V; Felder S; Kris R
J Mol Neurosci; 1989; 1(4):235-42. PubMed ID: 2561955
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II.
Kahán Z; Sun B; Schally AV; Arencibia JM; Cai RZ; Groot K; Halmos G
Cancer; 2000 Mar; 88(6):1384-92. PubMed ID: 10717621
[TBL] [Abstract][Full Text] [Related]
12. Expression of gastrin-releasing peptide receptors in endometrial cancer.
Levine L; Licci JA; Townsend CM; Hellmich MR
J Am Coll Surg; 2003 Jun; 196(6):898-904. PubMed ID: 12788426
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of bombesin on growth of gastrinoma (PT) in vivo.
Chu KU; Ishizuka J; Battey JF; Uchida T; Beauchamp RD; Townsend CM; Thompson JC
Dig Dis Sci; 1996 Nov; 41(11):2180-6. PubMed ID: 8943970
[TBL] [Abstract][Full Text] [Related]
14. Gastrin-releasing peptide is a growth factor for human neuroblastomas.
Kim S; Hu W; Kelly DR; Hellmich MR; Evers BM; Chung DH
Ann Surg; 2002 May; 235(5):621-9; discussion 629-30. PubMed ID: 11981207
[TBL] [Abstract][Full Text] [Related]
15. Developmental expression and biological activity of gastrin-releasing peptide and its receptors in the kidney.
Dumesny C; Whitley JC; Baldwin GS; Giraud AS; Shulkes A
Am J Physiol Renal Physiol; 2004 Sep; 287(3):F578-85. PubMed ID: 15140764
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix.
Chatzistamou I; Schally AV; Szepeshazi K; Groot K; Hebert F; Arencibia JM
Cancer Lett; 2001 Sep; 171(1):37-45. PubMed ID: 11485826
[TBL] [Abstract][Full Text] [Related]
17. Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines.
Cardona C; Rabbitts PH; Spindel ER; Ghatei MA; Bleehen NM; Bloom SR; Reeve JG
Cancer Res; 1991 Oct; 51(19):5205-11. PubMed ID: 1717141
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of a new bombesin analog for imaging of gastrin-releasing peptide receptors.
Shirmardi SP; Gandomkar M; Maragheh MG; Shamsaei M
Cancer Biother Radiopharm; 2011 Jun; 26(3):309-16. PubMed ID: 21711115
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
20. Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck.
Lango MN; Dyer KF; Lui VW; Gooding WE; Gubish C; Siegfried JM; Grandis JR
J Natl Cancer Inst; 2002 Mar; 94(5):375-83. PubMed ID: 11880476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
